- Global Locations -


Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705


Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531


Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates


Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Peptide Antibiotics Market Overview (2022 to 2032)

The global peptide antibiotics market was valued at around US$ 4.4 Billion at the end of 2021. The market is projected to register a 6.6% CAGR and top a valuation of US$ 8.3 Billion by 2032.

The market for peptide antibiotics is likely to thrive in the future given the rising incidence of disorders such as bloodstream infections, hospital-acquired infections, and bacterial skin infections.

Peptide antibiotics are peptides having strong antibacterial and antifungal properties. Peptide antibiotics are an essential part of the innate immune system, which living organisms rely on as their first line of defense against invading pathogens. The primary sites for the synthesis of these peptides are tissues that have direct environmental contact, such as the skin, gut, and lungs.

Peptide antibiotics are anti-infective and anti-tumor medicines that contain polypeptide chains. Peptide antibiotics come in two varieties: ribosomally synthesized peptide antibiotics and non-ribosomally synthesized peptide antibiotics. The advantages of peptide antibiotics include high specificity, high efficacy, and low toxicity.



Peptide Antibiotics Market Value in 2021

US$ 4.4 Billion

Peptide Antibiotics Market Value in 2032

US$ 8.3 Billion

Peptide Antibiotics Market CAGR (2022 to 2032)


Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Major Drivers Boosting the Demand for Peptide Antibiotics Market?

In light of factors like rising peptide antibiotic research & development activity and a high number of product approvals, the market is anticipated to experience potential growth. Additionally, the potential for side effects from traditional antibiotics and the rise in occurrences of antimicrobial resistance are anticipated to fuel the market throughout the forecast period.

Over the projected period, rising rates of cancer and other related infections are expected to spur growth. Some peptide antibiotics are prescribed to treat malignancies such as Hodgkin's lymphoma and a few different kinds of skin cancers. Globocan 2020 reports that there were 83,087 instances of Hodgkin's lymphoma and 5,44,352 cases of non-Hodgkin lymphoma. Due to doctor recommendations, it is anticipated that the effectiveness of various existing products would result in higher sales. BLEOMYCIN for injection is a combination of cytotoxic glycopeptide antibiotics, which is derived from the bacterium Streptomyces verticillus. It is utilized for the treatment of testicular cancer, squamous cell carcinoma, and other types of lymphomas.

Which Region Shows Strong Growth Potential in the Peptide Antibiotics Market?

The peptide antibiotics market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

The largest market for peptide antibiotics is in North America. Increased Research and Development activities in the region are anticipated to fuel the market over the projected period due to the region's increased demand for antibiotics.

The European peptide antibiotics industry is likewise anticipated to experience profitable expansion. Some of the important drivers of growth are the existence of major manufacturers and strategic initiatives undertaken by prominent companies.

The East Asian region is predicted to show lucrative growth owing to increasing rates of infectious disease and the vast presence of the elderly population.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Who are the Key Players in the Peptide Antibiotics Market?

Pfizer Inc., Merck & Co., Inc., AbbVie Inc, GSK Group of Companies, Sandoz International GmbH, Xellia Pharmaceuticals, AuroMedics Pharma LLC, Theravance Biopharma, Novartis, GlaxoSmithKline, Eli Lilly.

Scope of Report

Report Attributes


Growth Rate

CAGR of 6.6% from 2022 to 2032

Base Year for Estimation


Historical Data

2012 to 2021

Forecast Period

2022 to 2032

Qualitative Units

Revenue in USD Billion, and CAGR from 2022 to 2032

Report Coverage

Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends

Segment Covered

  • Product
  • Disease
  • Route of Administration
  • Distribution Channel
  • Region

Region Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Key Countries Profiled

  • USA
  • Canada
  • Brazil
  • Mexico
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • GCC Countries
  • South Africa
  • Israel

Key Players

  • Pfizer Inc.
  • Merck & Co., Inc.
  • AbbVie Inc
  • GSK Group of Companies
  • Sandoz International GmbH
  • Xellia Pharmaceuticals
  • AuroMedics Pharma LLC
  • Theravance Biopharma
  • Novartis
  • GlaxoSmithKline
  • Eli Lilly


Available Upon Request

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Segments Covered in the Peptide Antibiotics Market Report

By Product:

  • Ribosomal Synthesized Peptide Antibiotics
  • Non-Ribosomal Synthesized Peptide Antibiotics

By Disease:

  • Skin Infection
  • Blood Stream Infection
  • Others

By Route of Administration:

  • Oral
  • Injectable
  • Topical

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

What is the Growth Outlook for the Global Peptide Antibiotics Market?

The global peptide antibiotics market is anticipated to register a CAGR of 6.6% during the forecast period.

What is the Projected Value of the Global Peptide Antibiotics Market in 2032?

The global peptide antibiotics market is projected to be about US$ 8.3 Billion by the end of the year 2032.

Explore Healthcare Insights

View Reports

Peptide Antibiotics Market

Schedule a Call